ELEDON PHARMACEUTICALS INC's ticker is ELDN and the CUSIP is 28617K101. A total of 33 filers reported holding ELEDON PHARMACEUTICALS INC in Q2 2024. The put-call ratio across all filers is - and the average weighting 0.1%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SPHERA FUNDS MANAGEMENT LTD. | 1,297,021 | $3,424,135 | 0.47% |
| BVF INC/IL | 6,293,282 | $16,614,264 | 0.47% |
| CM Management, LLC | 160,000 | $422,400 | 0.39% |
| Zimmer Partners, LP | 2,109,704 | $5,569,619 | 0.10% |
| Nantahala Capital Management | 600,000 | $1,584,000 | 0.09% |
| ARMISTICE CAPITAL, LLC | 2,336,000 | $6,167,040 | 0.08% |
| JMAC ENTERPRISES LLC | 58,041 | $153,228 | 0.03% |
| Schonfeld Strategic Advisors LLC | 1,500,000 | $3,960,000 | 0.03% |
| Woodline Partners LP | 675,243 | $1,782,642 | 0.02% |
| Alyeska Investment Group, L.P. | 500,000 | $1,320,000 | 0.01% |
| MARCO INVESTMENT MANAGEMENT LLC | 30,344 | $80,108 | 0.01% |
| INGALLS & SNYDER LLC | 51,849 | $137 | 0.01% |
| Ensign Peak Advisors, Inc | 443,001 | $1,169,523 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 33,400 | $88,176 | 0.00% |
| Tower Research Capital LLC (TRC) | 16,958 | $44,769 | 0.00% |
| Renaissance Technologies | 136,773 | $361,081 | 0.00% |
| BlackRock Inc. | 155,080 | $409,411 | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 21,788 | $57,520 | 0.00% |
| JPMORGAN CHASE & CO | 91 | $240 | 0.00% |
| MORGAN STANLEY | 2,155 | $5,689 | 0.00% |
External links
This page lists ELEDON PHARMACEUTICALS INC's shareholders in Q2 2024. To view ELEDON PHARMACEUTICALS INC's shareholder history, click here.